{"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-10-17", "Rating": [{"Date": "2022-10-17", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$760"}, {"Date": "2022-09-09", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$625 to $851"}, {"Date": "2022-09-09", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Underperform to Hold", "Target_Change": "$536 to $675"}, {"Date": "2022-07-25", "Rating": "Downgrade", "Organization": "SVB Leerink", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$630"}, {"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Neutral", "Target_Change": "$625"}, {"Date": "2022-06-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$536"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$738"}, {"Date": "2022-01-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$675 to $575"}, {"Date": "2022-01-03", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$660"}, {"Date": "2021-12-15", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$660"}, {"Date": "2021-12-09", "Rating": "Resumed", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$750"}, {"Date": "2021-12-07", "Rating": "Resumed", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$625"}, {"Date": "2021-12-06", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$824"}, {"Date": "2021-11-19", "Rating": "Resumed", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$780"}, {"Date": "2021-11-05", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2021-06-29", "Rating": "Initiated", "Organization": "H.C. Wainwright", "Rating_Change": "Buy", "Target_Change": "$703"}, {"Date": "2021-01-25", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$630"}, {"Date": "2021-01-13", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Buy", "Target_Change": "$590"}, {"Date": "2021-01-08", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$635 to $575"}, {"Date": "2020-10-05", "Rating": "Upgrade", "Organization": "Cantor Fitzgerald", "Rating_Change": "Neutral to Overweight", "Target_Change": "$690"}, {"Date": "2020-08-20", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2020-07-09", "Rating": "Upgrade", "Organization": "SunTrust", "Rating_Change": "Hold to Buy", "Target_Change": "$400 to $750"}, {"Date": "2020-05-26", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$559 to $734"}, {"Date": "2020-04-28", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$540 to $575"}, {"Date": "2020-04-17", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Buy", "Target_Change": "$655"}, {"Date": "2020-04-08", "Rating": "Initiated", "Organization": "The Benchmark Company", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2020-03-31", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2020-02-27", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$530"}, {"Date": "2020-02-26", "Rating": "Upgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Hold to Buy", "Target_Change": "$550"}]}